INAD Warriors is pleased to announce the result of a $100,000 grant call aimed at advancing research in PLA2G6-associated Neurodegeneration (PLAN) disorders which includes Infantile Neuroaxonal Dystrophy (INAD).
Gateway Human Performance is proud to announce its official launch as the premier destination for sports performance and personal training in the Denver area.
Prepare to embark on a transformative journey with renowned healer and emotional trauma expert, Antonia Harman, as she hosts a groundbreaking virtual PTSD Trauma Healing event on July 12th, 2024.
IVIEW Therapeutics Inc., a clinical stage biotechnology company advancing innovative treatments for ocular diseases, proudly announces the dosing of the first patient in the Phase 1/2 clinical trial of IVW-1001 Ophthalmic Eyelid Wipe.
Mental health industry watchdog praises recent Senate Committee on Finance report for exposing egregious systemic abuse of youths within the behavioral treatment industry.
INAD Warriors is pleased to announce the result of a $100,000 grant call aimed at advancing research in PLA2G6-associated Neurodegeneration (PLAN) disorders which includes Infantile Neuroaxonal Dystrophy (INAD).
Gateway Human Performance is proud to announce its official launch as the premier destination for sports performance and personal training in the Denver area.
Prepare to embark on a transformative journey with renowned healer and emotional trauma expert, Antonia Harman, as she hosts a groundbreaking virtual PTSD Trauma Healing event on July 12th, 2024.
Engineers at the University of California, Los Angeles (UCLA) have unveiled a major advancement in optical computing technology that promises to enhance data processing and encryption.
Discover how APPSeCONNECT's latest solution addresses bulk data upload challenges for Amazon merchants using the SP Feeds API. Achieve efficient, seamless data synchronization and streamline your operations.
APPSeCONNECT announces the renewal of its SAP certification. This certification ensures that APPSeCONNECT 7.0.0.0 is fully compliant with SAP Business One for SAP HANA, reinforcing its commitment to providing reliable SAP integration.
IVIEW Therapeutics Inc., a clinical stage biotechnology company advancing innovative treatments for ocular diseases, proudly announces the dosing of the first patient in the Phase 1/2 clinical trial of IVW-1001 Ophthalmic Eyelid Wipe.
Mental health industry watchdog praises recent Senate Committee on Finance report for exposing egregious systemic abuse of youths within the behavioral treatment industry.
